Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).
- Citation:
- J Clin Oncol vol 22 (6) 1025-33
- Year:
- 2004
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA03927, CA11789, CA31946, CA31983, CA41287, CA47577, CA60138, CA77440
- Corr. Author:
- Eric J Small
- Authors:
- Eric J Small Susan Halabi Nancy A Dawson Walter M Stadler Brian I Rini Joel Picus Preston Gable Frank M Torti Ellen Kaplan Nicholas J Vogelzang
- Networks:
- Study
- CALGB-9583
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adenocarcinoma, Aged, Androgen Antagonists, Antineoplastic Agents, Hormonal, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Humans, Hydrocortisone, Ketoconazole, Male, Prospective Studies, Prostate-Specific Antigen, Prostatic Neoplasms, Survival Analysis